News & Updates

New drug applications approved by US FDA as of 1-15 November 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Early intratracheal budesonide in extremely preterm infants receiving surfactant for respiratory distress syndrome appears to be of little to no benefit in terms of survival free of bronchopulmonary dysplasia (BPD), according to a study.

Depressive symptoms are a risk factor for new-onset home hypertension, as reported in a study.

The risk of new or recurrent cancer related to inflammatory bowel disease (IBD) treatment does not appear to be elevated for IBD patients with a history of breast cancer, according to a large retrospective study.

A gluten-free diet (GFD), which involves higher sugar and fat intakes, may result in greater BMI in some patients with celiac disease (CD), according to a study.